title: Effects of chemotherapy in patients with dental implants.
abstract: Endosseous implant placement is generally considered to be contra-indicated in patients undergoing chemotherapy for the treatment of cancer. A case is presented where a patient was diagnosed with cancer and began chemotherapy four weeks after endosseous implants were placed. The impact of chemotherapeutic agents on endosseous implant acceptance as well as upon oral tissue is examined.
authors.affiliation: Department of Surgical/Hospital Dentistry, University of Louisville, School of Dentistry, Kentucky, USA.
authors.forename: M
authors.initials: M
authors.lastname: Steiner
authors.forename: A
authors.initials: A
authors.lastname: Windchy
authors.forename: A R
authors.initials: AR
authors.lastname: Gould
authors.forename: G M
authors.initials: GM
authors.lastname: Kushner
authors.forename: R
authors.initials: R
authors.lastname: Weber
mesh_terms: D000008:Abdominal Neoplasms / Q000188:drug therapy; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D017742:Dental Care for Chronically Ill; D003758:Dental Implantation, Endosseous; D015921:Dental Implants; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D016348:Osseointegration / Q000187:drug effects*; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects; D014945:Wound Healing / Q000187:drug effects
chemical_list: D015921:Dental Implants; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone